pembrolizumab
merck
['kn-407', 'lung']
5-years os update kn-407
hey, wait 5 years-os on metastatic lung cancer? yes 5yos: 18.4% vs 9.7% 5ypfs: 10.8% vs 3.5%
very pour our contribution a new standard of care. cure patients should be our goal #esmo22 #oncoalert 
Medical Oncologist. Lung Cancer specialist. Born in Salamanca. Director de la Estrategia de Cáncer en Andalucía. Opiniones personales #pandemiacáncer